Epstein Barr virus in Argentine pediatric Hodgkin's disease.
Since Hodgkin's disease (HD) is an heterogeneous condition with diverse histological and epidemiological subgroups, it seemed worthwhile to investigate the Argentine pediatric pattern. Moreover, the presence of Epstein Barr virus (EBV) infection occurs at different ages depending on the development status of the country. Thus, it was interesting to assess the relation between EBV and HD in the Argentine pediatric population. The age distribution profile of our pediatric HD patients showed a peak in early childhood which declined towards adolescence, closely resembling EBV infection pattern. Male:female ratio of the studied population was 3.2:1 and the histological subtype distribution disclosed that mixed cellularity HD (MCHD) was the most common, an epidemiological profile shared with other developing countries. Fifty percent of assessed HD cases were associated with EBV, showing a significantly higher prevalence in the 3-6 years-old group, indicating a non-random distribution. EBV was also present in most of MCHD cases and in some nodular lymphocyte predominance HD (nLPHD) but entirely absent in nodular sclerosis HD (NSHD). Both EBV subtypes, namely EBV-1 and EBV-2, were detected in studied HD cases. EBV-HD association in the Argentine pediatric population reveals typical epidemiological features indicating EBV as the aetiologic agent or, alternatively as a cofactor in a considerable percentage of such HD cases.
Preciado
M V
MV
Laboratory of Virology, Ricardo Guiterrez Children Hospital, Buenos Aires, Argentina.
Diez
B
B
Grinstein
S
S
D000293:Adolescent; D017677:Age Distribution; D000914:Antibodies, Viral / Q000032:analysis; D001118:Argentina / Q000453:epidemiology; D015415:Biomarkers; D002648:Child; D002675:Child, Preschool; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006566:Herpesviridae Infections / Q000453:epidemiology*; D004854:Herpesvirus 4, Human / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification* / Q000472:pathogenicity; D006689:Hodgkin Disease / Q000453:epidemiology / Q000209:etiology / Q000821:virology*; D006801:Humans; D007223:Infant; D008297:Male; D016133:Polymerase Chain Reaction; D014412:Tumor Virus Infections / Q000453:epidemiology*; D014764:Viral Proteins / Q000032:analysis; D017735:Virus Latency
D000914:Antibodies, Viral; D015415:Biomarkers; D004279:DNA, Viral; D014764:Viral Proteins